Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting Corticotroph HDAC and PI3-Kinase in Cushing Disease

The Journal of Clinical Endocrinology & Metabolism(2020)10.1210/clinem/dgaa699Source: DataRank Database

Targeting Corticotroph HDAC and PI3-Kinase in Cushing Disease is a research paper published in The Journal of Clinical Endocrinology & Metabolism (2020). On theSindex it has a DataRank of 0. It has been cited 27 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access27 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.17)OA: greenTopics (61)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Robert Damoiseaux ORCID,Lilit Babayan,Everett Kanediel Rivera-Meza,Yingying Yang ORCID,Marvin Bergsneider

Live enrichment

PubMed:33000123 PMC:PMC8921634 OpenAlex:https://openalex.org/W3090331344

Multi-campus Research Programs

Grant: MRP-17-454909

NCI NIH HHS

Grant: P30 CA016042

NCI NIH HHS

Grant: P50 CA211015

NIH

FWCI

1.17

Citation Percentile

0.8%

Citation Trend

2020

2022

2023

2024

2025

greenLicense: https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8921634

publisherhttps://academic.oup.com/jcem/article-pdf/106/1/e232/42895706/dgaa699.pdf

journalhttps://doi.org/10.1210/clinem/dgaa699

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33000123

Fields of Study

Pituitary Gland Disorders and TreatmentsAdrenal and Paraganglionic TumorsHistone Deacetylase Inhibitors ResearchACTH-Secreting Pituitary AdenomaAdenomaAdrenocorticotropic HormoneAnimalsAntineoplastic AgentsCell ProliferationCorticotrophsGene Expression Regulation, NeoplasticHigh-Throughput Screening AssaysHistone Deacetylase InhibitorsHumansMiceMice, NudeMolecular Targeted TherapyMorpholinesPhosphoinositide-3 Kinase InhibitorsPituitary ACTH HypersecretionPyrimidinesTumor Cells, CulturedXenograft Model Antitumor Assays

MeSH Terms

Phosphoinositide-3 Kinase InhibitorsAdenomaAdrenocorticotropic HormoneAnimalsAntineoplastic AgentsHumansMice, NudeMorpholinesPyrimidinesTumor Cells, CulturedGene Expression Regulation, NeoplasticXenograft Model Antitumor AssaysPituitary ACTH HypersecretionCell ProliferationACTH-Secreting Pituitary AdenomaMiceCorticotrophsHistone Deacetylase InhibitorsHigh-Throughput Screening AssaysMolecular Targeted Therapy

Keywords

Corticotropic cellCushing's diseaseMedicineCushing DiseaseInternal medicineEndocrinologyCushing syndromeCancer researchDiseasePituitary glandHormoneHistone deacetylasePituitary adenomaPhosphoinositide 3-kinaseAdrenocorticotropic HormoneHigh Throughput ScreenAmplified Luminescent Proximity Homogeneous AssayCudc-907 (Fimeprinostat)

Sustainable Development Goals

SDG 0: Good health and well-being

Targeting Corticotroph HDAC and PI3-Kinase in Cushing Disease

FAIR Checklist

Authors (10)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)